Skip to main content
logo
Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
43.55
-1.35 (-3.01%)
Apr 20, 2026, 1:42 PM EDT - Market open

KNSA Revenue

In the year 2025, Kiniksa Pharmaceuticals International, had annual revenue of $677.56M with 60.09% growth. Kiniksa Pharmaceuticals International, had revenue of $202.13M in the quarter ending December 31, 2025, with 64.95% growth.

Revenue (ttm)
$677.56M
Revenue Growth
+60.09%
P/S Ratio
5.07
Revenue / Employee
$1,851,268
Employees
366
Market Cap
3.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025677.56M254.33M60.09%
Dec 31, 2024423.24M152.98M56.60%
Dec 31, 2023270.26M50.08M22.74%
Dec 31, 2022220.18M181.64M471.24%
Dec 31, 202138.54M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Bausch Health Companies10.27B
Amneal Pharmaceuticals3.02B
Lantheus Holdings1.54B
Alkermes1.48B
Phibro Animal Health1.46B
Prestige Consumer Healthcare1.10B
BioCryst Pharmaceuticals874.84M
Supernus Pharmaceuticals718.95M
Revenue Rankings

KNSA News

More News